NDMM-话题@MedSci

#NDMM#

0篇内容 | 828人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2234812, encodeId=b86622348125f, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a>, objectTitle=【NEJM】isatuximab-VRd对比VRd治疗不适合移植NDMM的3期研究结果, objectType=article, longId=849581, objectId=f27a8495811e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401031/1730370086138_8538692.png, objectUrl=/article/show_article.do?id=f27a8495811e, replyNumber=0, likeNumber=27, createdTime=2024-11-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f27a8495811e, moduleTitle=【NEJM】isatuximab-VRd对比VRd治疗不适合移植NDMM的3期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f27a8495811e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2229529, encodeId=988f22295295a, content=<a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a>, objectTitle=【Blood】地塞米松剂量强度不影响NDMM生存期, objectType=article, longId=845911, objectId=ec9984591188, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240614/1718360011206_92910.jpg, objectUrl=/article/show_article.do?id=ec9984591188, replyNumber=0, likeNumber=73, createdTime=2024-10-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ec9984591188, moduleTitle=【Blood】地塞米松剂量强度不影响NDMM生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec9984591188)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2228822, encodeId=11122228822df, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=7f389396e27' target=_blank style='color:#2F92EE;'>#达雷妥尤单抗#</a> <a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a>, objectTitle=【Blood】NDMM移植后达雷妥尤单抗联合来那度胺维持治疗的AURIGA研究结果, objectType=article, longId=845471, objectId=f7238454e1c4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720669414779_5579292.png, objectUrl=/article/show_article.do?id=f7238454e1c4, replyNumber=0, likeNumber=58, createdTime=2024-10-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f7238454e1c4, moduleTitle=【Blood】NDMM移植后达雷妥尤单抗联合来那度胺维持治疗的AURIGA研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7238454e1c4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2217354, encodeId=0cd0221e3546b, content=<a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a> <a href='/topic/show?id=60c011e2152d' target=_blank style='color:#2F92EE;'>#DRd#</a>, objectTitle=【BJH】功能性高危适合移植NDMM，DRd联合移植有效, objectType=article, longId=836627, objectId=786b83662e99, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240726/1721988964751_8538692.jpg, objectUrl=/article/show_article.do?id=786b83662e99, replyNumber=0, likeNumber=127, createdTime=2024-07-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=786b83662e99, moduleTitle=【BJH】功能性高危适合移植NDMM，DRd联合移植有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=786b83662e99)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2210506, encodeId=74cf22105067d, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a> <a href='/topic/show?id=c8431154e5fb' target=_blank style='color:#2F92EE;'>#2024 EHA#</a>, objectTitle=客观缓解率100%！CAR-T细胞疗法治疗骨髓瘤再添好消息 | 2024 EHA, objectType=article, longId=830682, objectId=127c830682d7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240618/1718697468656_1608702.png, objectUrl=/article/show_article.do?id=127c830682d7, replyNumber=0, likeNumber=97, createdTime=2024-06-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=127c830682d7, moduleTitle=客观缓解率100%！CAR-T细胞疗法治疗骨髓瘤再添好消息 | 2024 EHA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=127c830682d7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2210095, encodeId=64b6221009532, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a> <a href='/topic/show?id=c4ea11555507' target=_blank style='color:#2F92EE;'>#Isa-VRd#</a>, objectTitle=【Nat Med】Isa-VRd对比IsaRd治疗不适合移植NDMM的3期研究, objectType=article, longId=830268, objectId=2002830268d0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240615/1718464821382_92910.png, objectUrl=/article/show_article.do?id=2002830268d0, replyNumber=0, likeNumber=91, createdTime=2024-06-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2002830268d0, moduleTitle=【Nat Med】Isa-VRd对比IsaRd治疗不适合移植NDMM的3期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2002830268d0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2200991, encodeId=79de2200991d9, content=<a href='/topic/show?id=7f389396e27' target=_blank style='color:#2F92EE;'>#达雷妥尤单抗#</a> <a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a>, objectTitle=BCJ：含达雷妥尤单抗四药方案治疗适合移植细胞遗传学高危NDMM的整体价值, objectType=article, longId=823722, objectId=c88a823e229a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-PWMEPKJ.jpg, objectUrl=/article/show_article.do?id=c88a823e229a, replyNumber=0, likeNumber=145, createdTime=2024-04-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c88a823e229a, moduleTitle=BCJ：含达雷妥尤单抗四药方案治疗适合移植细胞遗传学高危NDMM的整体价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c88a823e229a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2199897, encodeId=49be219989e6b, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=ce76105e57f' target=_blank style='color:#2F92EE;'>#KRd#</a> <a href='/topic/show?id=22dc1136e00c' target=_blank style='color:#2F92EE;'>#VRd#</a> <a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a>, objectTitle=【AJH】KRd对比VRd治疗NDMM的疗效：一项系统回顾和Meta分析, objectType=article, longId=822755, objectId=a622822e553e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-PTE4SCK.jpg, objectUrl=/article/show_article.do?id=a622822e553e, replyNumber=0, likeNumber=95, createdTime=2024-04-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a622822e553e, moduleTitle=【AJH】KRd对比VRd治疗NDMM的疗效：一项系统回顾和Meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a622822e553e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190269, encodeId=40b92190269d1, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=5ccae366556' target=_blank style='color:#2F92EE;'>#硼替佐米#</a> <a href='/topic/show?id=8face99717c' target=_blank style='color:#2F92EE;'>#美法仑#</a> <a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a>, objectTitle=【BMT】NDMM骨架硼替佐米+美法仑强化未负担美法仑单药：EBMT回顾性分析, objectType=article, longId=815228, objectId=abf9815228e0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016299208_4754896.png, objectUrl=/article/show_article.do?id=abf9815228e0, replyNumber=0, likeNumber=104, createdTime=2024-03-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=abf9815228e0, moduleTitle=【BMT】NDMM骨架硼替佐米+美法仑强化未负担美法仑单药：EBMT回顾性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abf9815228e0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2187826, encodeId=2fbe218e826be, content=<a href='/topic/show?id=3ec02566625' target=_blank style='color:#2F92EE;'>#伊沙佐米#</a> <a href='/topic/show?id=25e99031628' target=_blank style='color:#2F92EE;'>#衰弱#</a> <a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a>, objectTitle=【EClinicalMedicine】含伊沙佐米方案治疗老年衰弱NDMM的中国前瞻性研究, objectType=article, longId=813569, objectId=ab5281356966, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=ab5281356966, replyNumber=0, likeNumber=81, createdTime=2024-02-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=ab5281356966, moduleTitle=【EClinicalMedicine】含伊沙佐米方案治疗老年衰弱NDMM的中国前瞻性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab5281356966)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2184638, encodeId=55052184638b2, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a> <a href='/topic/show?id=938211066976' target=_blank style='color:#2F92EE;'>#D-VRd#</a>, objectTitle=【NEJM】D-VRd治疗NDMM的3期研究正式发表，附专家评述, objectType=article, longId=811444, objectId=eb9281144471, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-team-discussing-together-in-the-hallway-PJWSSDB.jpg, objectUrl=/article/show_article.do?id=eb9281144471, replyNumber=0, likeNumber=79, createdTime=2024-01-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=eb9281144471, moduleTitle=【NEJM】D-VRd治疗NDMM的3期研究正式发表，附专家评述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb9281144471)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2183952, encodeId=269c218395262, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a> <a href='/topic/show?id=dd41110532f5' target=_blank style='color:#2F92EE;'>#MAF易位#</a>, objectTitle=【Haematologica】安刚/邱录贵团队证实NDMM中MAF易位仍是强有力的预后因素, objectType=article, longId=810883, objectId=172f810883ea, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301012/1697153847368_4754896.jpeg, objectUrl=/article/show_article.do?id=172f810883ea, replyNumber=0, likeNumber=90, createdTime=2024-01-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=172f810883ea, moduleTitle=【Haematologica】安刚/邱录贵团队证实NDMM中MAF易位仍是强有力的预后因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=172f810883ea)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯管理员

多发性骨髓瘤 NDMM MAF易位

2024-01-25发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #NDMM#

【NEJM】isatuximab-VRd对比VRd治疗不适合移植NDMM的3期研究结果

2024-11-02发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#地塞米松# #NDMM#

【Blood】地塞米松剂量强度不影响NDMM生存期

2024-10-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #达雷妥尤单抗# #NDMM#

【Blood】NDMM移植后达雷妥尤单抗联合来那度胺维持治疗的AURIGA研究结果

2024-10-01发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#NDMM# #DRd#

【BJH】功能性高危适合移植NDMM，DRd联合移植有效

2024-07-29发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #NDMM# #2024 EHA#

客观缓解率100%！CAR-T细胞疗法治疗骨髓瘤再添好消息 | 2024 EHA

2024-06-18发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #NDMM# #Isa-VRd#

【Nat Med】Isa-VRd对比IsaRd治疗不适合移植NDMM的3期研究

2024-06-15发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#达雷妥尤单抗# #NDMM#

BCJ：含达雷妥尤单抗四药方案治疗适合移植细胞遗传学高危NDMM的整体价值

2024-04-29发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #KRd# #VRd# #NDMM#

【AJH】KRd对比VRd治疗NDMM的疗效：一项系统回顾和Meta分析

2024-04-23发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #硼替佐米# #美法仑# #NDMM#

【BMT】NDMM骨架硼替佐米+美法仑强化未负担美法仑单药：EBMT回顾性分析

2024-03-01发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#伊沙佐米# #衰弱# #NDMM#

【EClinicalMedicine】含伊沙佐米方案治疗老年衰弱NDMM的中国前瞻性研究

2024-02-17发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #NDMM# #D-VRd#

【NEJM】D-VRd治疗NDMM的3期研究正式发表，附专家评述

2024-01-29发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #NDMM# #MAF易位#

【Haematologica】安刚/邱录贵团队证实NDMM中MAF易位仍是强有力的预后因素

2024-01-25发表于陕西省

科室
- - 订阅+
  - 更多科室
工具
服务